Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

PURPOSE: Human epidermal growth factor receptor 2 (HER2) alterations are found in approximately 1%-3% of non-small cell lung cancers (NSCLCs). We evaluated the clinical features and outcomes of NSCLC harboring HER2 alteration detected by next-generation sequencing (NGS) in Korea. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kangkook, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962476/
https://www.ncbi.nlm.nih.gov/pubmed/31345011
http://dx.doi.org/10.4143/crt.2019.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962476/
https://www.ncbi.nlm.nih.gov/pubmed/31345011
http://dx.doi.org/10.4143/crt.2019.186

Ejemplares similares